Avid Bioservices Capabilities Update July 2026: Large Molecule

Bringing biologics from concept to commercial supply requires a manufacturing partner that can balance speed, quality, and scalability. Avid Bioservices combines more than 25 years of CDMO experience with integrated capabilities that support every stage of development, from cell line development and process optimization to clinical manufacturing and commercial production.

With modern California-based facilities, platformed technologies, and expertise spanning monoclonal antibodies, bispecifics, fusion proteins, enzymes, cytokines, and other recombinant proteins, Avid helps sponsors reduce development risk while maintaining regulatory readiness. Trusted by leading global pharmaceutical companies, the organization emphasizes reliable execution, transparent communication, and flexible program design tailored to individual client needs.

Learn how an end-to-end approach, supported by extensive manufacturing experience and a strong quality track record, can help accelerate timelines and support successful product commercialization.